Mineralys Therapeutics, Inc. (MLYS)

33.22 -2.12 (-6.01%) USD  |  NASDAQ  |  Jan 08, 16:00
33.48 +0.26 (+0.77%) After-Hours: 20:00
More

Mineralys Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for MLYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
Lyell Immunopharma, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade